ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/11 | 1,548 | 1,560 | 1,528 | 1,535 | -5 | -0.3% | 92,400 |
| 2017/07/10 | 1,549 | 1,566 | 1,533 | 1,540 | -8 | -0.5% | 86,700 |
| 2017/07/07 | 1,574 | 1,575 | 1,541 | 1,548 | -21 | -1.3% | 160,600 |
| 2017/07/06 | 1,564 | 1,576 | 1,554 | 1,569 | +1 | +0.1% | 61,000 |
| 2017/07/05 | 1,560 | 1,573 | 1,550 | 1,568 | -9 | -0.6% | 59,500 |
| 2017/07/04 | 1,566 | 1,584 | 1,544 | 1,577 | +15 | +1% | 258,700 |
| 2017/07/03 | 1,551 | 1,569 | 1,545 | 1,562 | +23 | +1.5% | 130,800 |
| 2017/06/30 | 1,539 | 1,545 | 1,531 | 1,539 | ±0 | ±0% | 47,200 |
| 2017/06/29 | 1,542 | 1,552 | 1,530 | 1,539 | -1 | -0.1% | 44,700 |
| 2017/06/28 | 1,550 | 1,552 | 1,527 | 1,540 | +1 | +0.1% | 52,400 |
| 2017/06/27 | 1,535 | 1,568 | 1,533 | 1,539 | +3 | +0.2% | 59,100 |
| 2017/06/26 | 1,525 | 1,549 | 1,525 | 1,536 | +14 | +0.9% | 75,500 |
| 2017/06/23 | 1,570 | 1,573 | 1,513 | 1,522 | -47 | -3% | 114,500 |
| 2017/06/22 | 1,555 | 1,579 | 1,541 | 1,569 | +33 | +2.1% | 112,400 |
| 2017/06/21 | 1,532 | 1,553 | 1,530 | 1,536 | +5 | +0.3% | 74,100 |
| 2017/06/20 | 1,569 | 1,569 | 1,531 | 1,531 | -28 | -1.8% | 79,300 |
| 2017/06/19 | 1,561 | 1,564 | 1,535 | 1,559 | -11 | -0.7% | 63,200 |
| 2017/06/16 | 1,576 | 1,588 | 1,555 | 1,570 | -18 | -1.1% | 110,100 |
| 2017/06/15 | 1,526 | 1,589 | 1,509 | 1,588 | +64 | +4.2% | 349,900 |
| 2017/06/14 | 1,531 | 1,545 | 1,506 | 1,524 | -8 | -0.5% | 74,700 |
| 2017/06/13 | 1,481 | 1,534 | 1,481 | 1,532 | +53 | +3.6% | 156,400 |
| 2017/06/12 | 1,492 | 1,510 | 1,474 | 1,479 | -3 | -0.2% | 109,600 |
| 2017/06/09 | 1,487 | 1,495 | 1,475 | 1,482 | -3 | -0.2% | 55,100 |
| 2017/06/08 | 1,494 | 1,500 | 1,470 | 1,485 | +5 | +0.3% | 42,600 |
| 2017/06/07 | 1,475 | 1,498 | 1,469 | 1,480 | -1 | -0.1% | 85,900 |
| 2017/06/06 | 1,500 | 1,500 | 1,481 | 1,481 | -21 | -1.4% | 94,200 |
| 2017/06/05 | 1,537 | 1,538 | 1,500 | 1,502 | -14 | -0.9% | 122,500 |
| 2017/06/02 | 1,522 | 1,533 | 1,516 | 1,516 | +1 | +0.1% | 43,700 |
| 2017/06/01 | 1,505 | 1,518 | 1,500 | 1,515 | +5 | +0.3% | 50,100 |
| 2017/05/31 | 1,511 | 1,538 | 1,507 | 1,510 | -5 | -0.3% | 38,500 |
| 2017/05/30 | 1,528 | 1,550 | 1,507 | 1,515 | -39 | -2.5% | 97,800 |
| 2017/05/29 | 1,568 | 1,580 | 1,502 | 1,554 | -3 | -0.2% | 62,500 |
| 2017/05/26 | 1,588 | 1,588 | 1,553 | 1,557 | -18 | -1.1% | 32,100 |
| 2017/05/25 | 1,549 | 1,580 | 1,528 | 1,575 | +27 | +1.7% | 62,300 |
| 2017/05/24 | 1,562 | 1,571 | 1,524 | 1,548 | -20 | -1.3% | 80,600 |
| 2017/05/23 | 1,570 | 1,590 | 1,558 | 1,568 | -2 | -0.1% | 22,700 |
| 2017/05/22 | 1,606 | 1,606 | 1,570 | 1,570 | -27 | -1.7% | 45,600 |
| 2017/05/19 | 1,614 | 1,623 | 1,581 | 1,597 | -53 | -3.2% | 94,100 |
| 2017/05/18 | 1,550 | 1,660 | 1,534 | 1,650 | +31 | +1.9% | 107,600 |
| 2017/05/17 | 1,640 | 1,640 | 1,601 | 1,619 | -24 | -1.5% | 54,500 |
| 2017/05/16 | 1,653 | 1,657 | 1,641 | 1,643 | -3 | -0.2% | 27,700 |
| 2017/05/15 | 1,669 | 1,670 | 1,646 | 1,646 | -7 | -0.4% | 31,300 |
| 2017/05/12 | 1,652 | 1,668 | 1,651 | 1,653 | +2 | +0.1% | 19,100 |
| 2017/05/11 | 1,695 | 1,698 | 1,650 | 1,651 | -43 | -2.5% | 70,200 |
| 2017/05/10 | 1,680 | 1,735 | 1,680 | 1,694 | +14 | +0.8% | 117,800 |
| 2017/05/09 | 1,699 | 1,717 | 1,680 | 1,680 | -19 | -1.1% | 56,900 |
| 2017/05/08 | 1,684 | 1,701 | 1,676 | 1,699 | +24 | +1.4% | 62,100 |
| 2017/05/02 | 1,680 | 1,681 | 1,665 | 1,675 | +10 | +0.6% | 29,700 |
| 2017/05/01 | 1,678 | 1,690 | 1,651 | 1,665 | -9 | -0.5% | 23,500 |
| 2017/04/28 | 1,665 | 1,676 | 1,651 | 1,674 | +8 | +0.5% | 23,100 |
1801～
1850
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
